{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T15:56:40Z","timestamp":1776959800572,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["81025018"],"award-info":[{"award-number":["81025018"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["81172969"],"award-info":[{"award-number":["81172969"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Major Project of China","award":["2013ZX10004001"],"award-info":[{"award-number":["2013ZX10004001"]}]},{"name":"Beijing Nature Science Foundation of China","award":["5122035"],"award-info":[{"award-number":["5122035"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunobiology"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.imbio.2013.08.008","type":"journal-article","created":{"date-parts":[[2013,8,23]],"date-time":"2013-08-23T16:46:36Z","timestamp":1377276396000},"page":"97-103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Deletion modification enhances anthrax specific immunity and protective efficacy of a hepatitis B core particle-based anthrax epitope vaccine"],"prefix":"10.1016","volume":"219","author":[{"given":"Ying","family":"Yin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenguang","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dayong","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junjie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.imbio.2013.08.008_bib0005","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.0818-9641.2004.01278.x","article-title":"Development of a nasal vaccine for chronic hepatitis B infection that uses the ability of hepatitis B core antigen to stimulate a strong Th1 response against hepatitis B surface antigen","volume":"82","author":"Aguilar","year":"2004","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.imbio.2013.08.008_bib0010","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/bioinformatics\/bti770","article-title":"The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling","volume":"22","author":"Arnold","year":"2006","journal-title":"Bioinformatics"},{"key":"10.1016\/j.imbio.2013.08.008_bib0015","doi-asserted-by":"crossref","first-page":"13641","DOI":"10.1128\/JVI.79.21.13641-13655.2005","article-title":"Comparative antigenicity and immunogenicity of hepadnavirus core proteins","volume":"79","author":"Billaud","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.imbio.2013.08.008_bib0020","doi-asserted-by":"crossref","first-page":"13656","DOI":"10.1128\/JVI.79.21.13656-13666.2005","article-title":"Combinatorial approach to hepadnavirus-like particle vaccine design","volume":"79","author":"Billaud","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.imbio.2013.08.008_bib0025","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/j.vaccine.2006.11.013","article-title":"Advantages to the use of rodent hepadnavirus core proteins as vaccine platforms","volume":"25","author":"Billaud","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.imbio.2013.08.008_bib0030","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.virol.2012.09.014","article-title":"A molecular assembly system for presentation of antigens on the surface of HBc virus-like particles","volume":"435","author":"Blokhina","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.imbio.2013.08.008_bib0035","first-page":"7","article-title":"Subcellular localization of hepatitis B virus core protein expressed from two different constructs in the Semliki Forest virus expression system","volume":"745","author":"Braun","year":"2008","journal-title":"Acta Univ. Latviensis"},{"key":"10.1016\/j.imbio.2013.08.008_bib0040","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev.cellbio.19.111301.140655","article-title":"Anthrax toxin","volume":"19","author":"Collier","year":"2003","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.imbio.2013.08.008_bib0045","doi-asserted-by":"crossref","first-page":"6503","DOI":"10.1016\/j.vaccine.2008.09.038","article-title":"Universal influenza A M2e-HBc vaccine protects against disease even in the presence of pre-existing anti-HBc antibodies","volume":"26","author":"De Filette","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.imbio.2013.08.008_bib0050","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.virusres.2004.02.030","article-title":"A \u201cuniversal\u201d human influenza A vaccine","volume":"103","author":"Fiers","year":"2004","journal-title":"Virus Res."},{"key":"10.1016\/j.imbio.2013.08.008_bib0055","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.pep.2010.09.010","article-title":"Highly efficient production of phosphorylated hepatitis B core particles in yeast Pichia pastoris","volume":"75","author":"Freivalds","year":"2011","journal-title":"Protein Expr. Purif."},{"issue":"Suppl. 4","key":"10.1016\/j.imbio.2013.08.008_bib0060","first-page":"D28L 32","article-title":"Advances in the development of next-generation anthrax vaccines","volume":"27","author":"Friedlander","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.imbio.2013.08.008_bib0065","doi-asserted-by":"crossref","first-page":"4645","DOI":"10.1128\/jvi.63.11.4645-4652.1989","article-title":"A recombinant hepatitis B core antigen polypeptide with the protamine-like domain deleted self-assembles into capsid particles but fails to bind nucleic acids","volume":"63","author":"Gallina","year":"1989","journal-title":"J. Virol."},{"key":"10.1016\/j.imbio.2013.08.008_bib0070","doi-asserted-by":"crossref","first-page":"3973","DOI":"10.1016\/j.vaccine.2005.02.025","article-title":"A hantavirus nucleocapsid protein segment exposed on hepatitis B virus core particles is highly immunogenic in mice when applied without adjuvants or in the presence of pre-existing anti-core antibodies","volume":"23","author":"Geldmacher","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.imbio.2013.08.008_bib0075","series-title":"Immunology","first-page":"57","author":"Goldsby","year":"2006"},{"key":"10.1016\/j.imbio.2013.08.008_bib0080","doi-asserted-by":"crossref","first-page":"e1556","DOI":"10.1371\/journal.pone.0001556","article-title":"Phase I trial of an alhydrogel adjuvanted hepatitis B core virus-like particle containing epitopes of Plasmodium falciparum circumsporozoite protein","volume":"3","author":"Gregson","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.imbio.2013.08.008_bib0085","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1002\/elps.1150181505","article-title":"SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling","volume":"18","author":"Guex","year":"1997","journal-title":"Electrophoresis"},{"key":"10.1016\/j.imbio.2013.08.008_bib0090","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s007260070072","article-title":"Insertion of foreign epitopes in HBcAg: how to make the chimeric particle assemble","volume":"18","author":"Karpenko","year":"2000","journal-title":"Amino Acids"},{"key":"10.1016\/j.imbio.2013.08.008_bib0095","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.vaccine.2012.10.083","article-title":"Virus-like particles as a highly efficient vaccine platform: diversity of targets and production systems and advances in clinical development","volume":"31","author":"Kushnir","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.imbio.2013.08.008_bib0100","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.pep.2013.02.012","article-title":"Secretory expression and efficient purification of recombinant anthrax toxin lethal factor with full biological activity in E. coli","volume":"89","author":"Liu","year":"2013","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.imbio.2013.08.008_bib0105","doi-asserted-by":"crossref","first-page":"14648","DOI":"10.1073\/pnas.94.26.14648","article-title":"Role of B cells in antigen presentation of the hepatitis B core","volume":"94","author":"Milich","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.imbio.2013.08.008_bib0110","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1146\/annurev.micro.55.1.647","article-title":"Anthrax","volume":"55","author":"Mock","year":"2001","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.imbio.2013.08.008_bib0115","doi-asserted-by":"crossref","first-page":"6519","DOI":"10.1128\/IAI.72.11.6519-6527.2004","article-title":"Phase I testing of a malaria vaccine composed of hepatitis B virus core particles expressing Plasmodium falciparum circumsporozoite epitopes","volume":"72","author":"Nardin","year":"2004","journal-title":"Infect. Immun."},{"key":"10.1016\/j.imbio.2013.08.008_bib0120","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/13484","article-title":"A universal influenza A vaccine based on the extracellular domain of the M2 protein","volume":"5","author":"Neirynck","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.imbio.2013.08.008_bib0125","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.1128\/IAI.73.6.3587-3597.2005","article-title":"Safety and enhanced immunogenicity of a hepatitis B core particle Plasmodium falciparum malaria vaccine formulated in adjuvant Montanide ISA 720 in a phase I trial","volume":"73","author":"Oliveira","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.imbio.2013.08.008_bib0130","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/385833a0","article-title":"Crystal structure of the anthrax toxin protective antigen","volume":"385","author":"Petosa","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.imbio.2013.08.008_bib0135","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000050037","article-title":"HBV core particles as a carrier for B cell\/T cell epitopes","volume":"44","author":"Pumpens","year":"2001","journal-title":"Intervirology"},{"key":"10.1016\/j.imbio.2013.08.008_bib0140","first-page":"33","article-title":"Plant-produced recombinant influenza vaccine based on virus-like HBc particles carrying an extracellular domain of M2 protein","volume":"77","author":"Ravin","year":"2012","journal-title":"Biochemistry"},{"key":"10.1016\/j.imbio.2013.08.008_bib0145","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1586\/erv.09.6","article-title":"Universal M2 ectodomain-based influenza A vaccines: preclinical and clinical developments","volume":"8","author":"Schotsaert","year":"2009","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.imbio.2013.08.008_bib0150","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1093\/nar\/gkg520","article-title":"SWISS-MODEL: an automated protein homology-modeling server","volume":"31","author":"Schwede","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.imbio.2013.08.008_bib0155","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0065-3527(08)60808-8","article-title":"Core particles of hepatitis B virus as carrier for foreign epitopes","volume":"50","author":"Ulrich","year":"1998","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.imbio.2013.08.008_bib0160","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/srep00005","article-title":"SplitCore: an exceptionally versatile viral nanoparticle for native whole protein display regardless of 3D structure","volume":"1","author":"Walker","year":"2011","journal-title":"Sci. Rep."},{"key":"10.1016\/j.imbio.2013.08.008_bib0165","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1586\/erv.09.121","article-title":"Use of hepadnavirus core proteins as vaccine platforms","volume":"8","author":"Whitacre","year":"2009","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.imbio.2013.08.008_bib0170","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S1097-2765(01)80009-5","article-title":"The crystal structure of the human hepatitis B virus capsid","volume":"3","author":"Wynne","year":"1999","journal-title":"Mol. Cell"},{"key":"10.1016\/j.imbio.2013.08.008_bib0175","doi-asserted-by":"crossref","first-page":"5814","DOI":"10.1016\/j.vaccine.2008.08.031","article-title":"Chimeric hepatitis B virus core particles carrying an epitope of anthrax protective antigen induce protective immunity against Bacillus anthracis","volume":"26","author":"Yin","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.imbio.2013.08.008_bib0180","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1146\/annurev.biochem.75.103004.142728","article-title":"Anthrax toxin: receptor binding, internalization, pore formation, and translocation","volume":"76","author":"Young","year":"2007","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.imbio.2013.08.008_bib0185","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s12033-012-9598-4","article-title":"Construction and characterization of virus-like particles: a review","volume":"53","author":"Zeltins","year":"2013","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.imbio.2013.08.008_bib0190","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.bbrc.2006.01.080","article-title":"The 2beta2\u20132beta3 loop of anthrax protective antigen contains a dominant neutralizing epitope","volume":"341","author":"Zhang","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Immunobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298513001587?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298513001587?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T16:36:43Z","timestamp":1759250203000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0171298513001587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0171298513001587"],"URL":"https:\/\/doi.org\/10.1016\/j.imbio.2013.08.008","relation":{},"ISSN":["0171-2985"],"issn-type":[{"value":"0171-2985","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deletion modification enhances anthrax specific immunity and protective efficacy of a hepatitis B core particle-based anthrax epitope vaccine","name":"articletitle","label":"Article Title"},{"value":"Immunobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imbio.2013.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}]}}